These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 21601014)

  • 1. Toll-like receptors in acute liver injury and regeneration.
    Chen Y; Sun R
    Int Immunopharmacol; 2011 Oct; 11(10):1433-41. PubMed ID: 21601014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptors and adaptor molecules in liver disease: update.
    Seki E; Brenner DA
    Hepatology; 2008 Jul; 48(1):322-35. PubMed ID: 18506843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Toll-like receptors in liver health and disease.
    Broering R; Lu M; Schlaak JF
    Clin Sci (Lond); 2011 Nov; 121(10):415-26. PubMed ID: 21797822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptors: a novel target for therapeutic intervention in intestinal and hepatic ischemia-reperfusion injury?
    Vasileiou I; Kostopanagiotou G; Katsargyris A; Klonaris C; Perrea D; Theocharis S
    Expert Opin Ther Targets; 2010 Aug; 14(8):839-53. PubMed ID: 20568914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and cytokine-mediated mechanisms of inflammation and its modulation in immune-mediated liver injury.
    Tiegs G
    Z Gastroenterol; 2007 Jan; 45(1):63-70. PubMed ID: 17236122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of toll-like receptors signaling in organ transplantation.
    Li T; Chen G; Zhang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Dec; 36(12):1125-33. PubMed ID: 22246357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid receptors as therapeutic targets in the management of liver diseases.
    Mallat A; Lotersztajn S
    Drug News Perspect; 2008 Sep; 21(7):363-8. PubMed ID: 19259549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate immune response and hepatic inflammation.
    Szabo G; Mandrekar P; Dolganiuc A
    Semin Liver Dis; 2007 Nov; 27(4):339-50. PubMed ID: 17979071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The essential roles of Toll-like receptor signaling pathways in sterile inflammatory diseases.
    Lin Q; Li M; Fang D; Fang J; Su SB
    Int Immunopharmacol; 2011 Oct; 11(10):1422-32. PubMed ID: 21600309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptors and their role in gastrointestinal disease.
    Testro AG; Visvanathan K
    J Gastroenterol Hepatol; 2009 Jun; 24(6):943-54. PubMed ID: 19638078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor signaling pathways and the evidence linking toll-like receptor signaling to cardiac ischemia/reperfusion injury.
    Wang Y; Abarbanell AM; Herrmann JL; Weil BR; Poynter J; Manukyan MC; Crisostomo PR; Meldrum DR
    Shock; 2010 Dec; 34(6):548-57. PubMed ID: 20458266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptors as targets in chronic liver diseases.
    Mencin A; Kluwe J; Schwabe RF
    Gut; 2009 May; 58(5):704-20. PubMed ID: 19359436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor signaling in the liver.
    Schwabe RF; Seki E; Brenner DA
    Gastroenterology; 2006 May; 130(6):1886-900. PubMed ID: 16697751
    [No Abstract]   [Full Text] [Related]  

  • 14. Toll-like receptors in inflammation of the central nervous system.
    Kong Y; Le Y
    Int Immunopharmacol; 2011 Oct; 11(10):1407-14. PubMed ID: 21600311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The roles of innate immune cells in liver injury and regeneration.
    Dong Z; Wei H; Sun R; Tian Z
    Cell Mol Immunol; 2007 Aug; 4(4):241-52. PubMed ID: 17764614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLRs and chronic inflammation.
    Ospelt C; Gay S
    Int J Biochem Cell Biol; 2010 Apr; 42(4):495-505. PubMed ID: 19840864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells.
    Paik YH; Schwabe RF; Bataller R; Russo MP; Jobin C; Brenner DA
    Hepatology; 2003 May; 37(5):1043-55. PubMed ID: 12717385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor function and signaling.
    Kaisho T; Akira S
    J Allergy Clin Immunol; 2006 May; 117(5):979-87; quiz 988. PubMed ID: 16675322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration.
    Seki E; Tsutsui H; Iimuro Y; Naka T; Son G; Akira S; Kishimoto T; Nakanishi K; Fujimoto J
    Hepatology; 2005 Mar; 41(3):443-50. PubMed ID: 15723296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptors and innate immunity.
    Kumar H; Kawai T; Akira S
    Biochem Biophys Res Commun; 2009 Oct; 388(4):621-5. PubMed ID: 19686699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.